Article: MIV Therapeutics Inc. Called to Trade on the Berlin Stock Exchange.

MIV Therapeutics Inc. (MIVT.OB :OTC BB) is pleased to announce the commencement of trading on the Berlin Stock Exchange under the symbol MIV.BE and German Cusip No.798618.

Mr. Alan Lindsay, Chairman, President and CEO of MIV Therapeutics stated, "The listing in Germany is an important event as our company will benefit from increased exposure to the European capital markets. European investors are showing a great deal of interest in MIV Therapeutics and will now have easier access to trade the company's shares.

Mr. Lindsay added, "We expect the stent industry will experience vertical growth with the development of coatings and therapeutics for stent ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!